TY - JOUR
T1 - Synergistic effect of umbilical cord extracellular vesicles and rhBMP-2 to enhance the regeneration of a metaphyseal femoral defect in osteoporotic rats
AU - Deluca, Amelie
AU - Wagner, Andrea
AU - Heimel, Patrick
AU - Deininger, Christian
AU - Wichlas, Florian
AU - Redl, Heinz
AU - Rohde, Eva
AU - Tempfer, Herbert
AU - Gimona, Mario
AU - Traweger, Andreas
N1 - Deluca, Wagner, Deininger, Tempfer, Traweger: Institute of Tendon and Bone Regeneration, Salzburg 5020, Austria; Deininger, Wichlas: Department of Orthopedics and Traumatology, Salzburg University Hospital, Paracelsus Medical University, Salzburg 5020, Austria; Rohde, Gimona: GMP Unit, Spinal Cord Injury and Tissue Regeneration Centre Salzburg, Paracelsus Medical University, Salzburg, Austria; Rohde, Department of Transfusion Medicine, Salzburger Landeskliniken GesmbH, Paracelsus Medical University, Salzburg, Austria; Gimona: esearch Program “Nanovesicular Therapies”, Paracelsus Medical
University, Salzburg, Austria
PY - 2024/5/20
Y1 - 2024/5/20
N2 - Background The aim of this study was to evaluate potential synergistic effects of a single, local application of human umbilical cord MSC-derived sEVs in combination with a low dose of recombinant human rhBMP-2 to promote the regeneration of a metaphyseal femoral defect in an osteoporotic rat model. Methods 6 weeks after induction of osteoporosis by bilateral ventral ovariectomy and administration of a special diet, a total of 64 rats underwent a distal femoral metaphyseal osteotomy using a manual Gigli wire saw. Defects were stabilized with an adapted Y-shaped mini-locking plate and were subsequently treated with alginate only, or alginate loaded with hUC-MSC-sEVs (2 x 109), rhBMP-2 (1.5 mu g), or a combination of sEVs and rhBMP-2 (n = 16 for each group). 6 weeks post-surgery, femora were evaluated by mu CT, descriptive histology, and biomechanical testing. Results Native radiographs and mu CT analysis confirmed superior bony union with callus formation after treatment with hUC-MSC-sEVs in combination with a low dose of rhBMP-2. This finding was further substantiated by histology, showing robust defect consolidation 6 weeks after treatment. Torsion testing of the explanted femora revealed increased stiffness after application of both, rhBMP-2 alone, or in combination with sEVs, whereas torque was only significantly increased after treatment with rhBMP-2 together with sEVs. Conclusion The present study demonstrates that the co-application of hUC-MSC-sEVs can improve the efficacy of rhBMP-2 to promote the regeneration of osteoporotic bone defects.
AB - Background The aim of this study was to evaluate potential synergistic effects of a single, local application of human umbilical cord MSC-derived sEVs in combination with a low dose of recombinant human rhBMP-2 to promote the regeneration of a metaphyseal femoral defect in an osteoporotic rat model. Methods 6 weeks after induction of osteoporosis by bilateral ventral ovariectomy and administration of a special diet, a total of 64 rats underwent a distal femoral metaphyseal osteotomy using a manual Gigli wire saw. Defects were stabilized with an adapted Y-shaped mini-locking plate and were subsequently treated with alginate only, or alginate loaded with hUC-MSC-sEVs (2 x 109), rhBMP-2 (1.5 mu g), or a combination of sEVs and rhBMP-2 (n = 16 for each group). 6 weeks post-surgery, femora were evaluated by mu CT, descriptive histology, and biomechanical testing. Results Native radiographs and mu CT analysis confirmed superior bony union with callus formation after treatment with hUC-MSC-sEVs in combination with a low dose of rhBMP-2. This finding was further substantiated by histology, showing robust defect consolidation 6 weeks after treatment. Torsion testing of the explanted femora revealed increased stiffness after application of both, rhBMP-2 alone, or in combination with sEVs, whereas torque was only significantly increased after treatment with rhBMP-2 together with sEVs. Conclusion The present study demonstrates that the co-application of hUC-MSC-sEVs can improve the efficacy of rhBMP-2 to promote the regeneration of osteoporotic bone defects.
KW - Animals
KW - Bone Morphogenetic Protein 2/pharmacology
KW - Recombinant Proteins/pharmacology
KW - Osteoporosis/pathology
KW - Rats
KW - Female
KW - Humans
KW - Femur/pathology
KW - Umbilical Cord/cytology
KW - Extracellular Vesicles/metabolism
KW - Bone Regeneration/drug effects
KW - Rats, Sprague-Dawley
KW - Transforming Growth Factor beta/pharmacology
KW - Disease Models, Animal
KW - X-Ray Microtomography
KW - Mesenchymal Stem Cells/metabolism
U2 - 10.1186/s13287-024-03755-8
DO - 10.1186/s13287-024-03755-8
M3 - Original Article
C2 - 38764077
SN - 1757-6512
VL - 15
SP - 144
JO - Stem cell research & therapy
JF - Stem cell research & therapy
IS - 1
M1 - 144
ER -